Meryl Zausner Seres Therapeutics, Inc. (MCRB) insider trading activity

MCRB Quotes by TradingView

Meryl Zausner is Director of Seres Therapeutics, Inc.. Currently has a direct ownership of 31,746 shares of MCRB, which is worth approximately $26,031. The most recent transaction as insider was on Jul 05, 2022, when has been sold 31,746 shares (Common Stock) at a price of $3.15 per share, resulting in proceeds of $100,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.7K
0% 3M change
0% 12M change
Total Value Held $26,031

Meryl Zausner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 05 2022
BUY
Grant, award, or other acquisition
$100,000 $3.15 p/Share
31,746 Added 50.0%
31,746 Common Stock
MZ

Meryl Zausner

Director
Cambridge, MA

Track Institutional and Insider Activities on MCRB

Follow Seres Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MCRB shares.

Notify only if

Insider Trading

Get notified when an Seres Therapeutics, Inc. insider buys or sells MCRB shares.

Notify only if

News

Receive news related to Seres Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MCRB